The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy.
PropertyValue
has major subject area list Drug Resistance, Neoplasm; Melanoma; Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins B-raf; Skin Neoplasms
has minor subject area list Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cell Line, Tumor; Clonal Evolution; Female; Humans; Imidazoles; Indoles; Male; Middle Aged; Oximes; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; ras Proteins; Sulfonamides; Vemurafenib
information resource reference Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy. Cancer Discov. 2014 Jan; 4(1):80-93.
label Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy.
Search Criteria
  • evolution
  • resistance